Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 9:01 PM ET

Date/Time Source News Release
12/17/2024 07:30 AM EST GlobeNewswire Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium
12/04/2024 07:30 AM EST GlobeNewswire Plus Therapeutics to Showcase ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium
12/03/2024 07:30 AM EST GlobeNewswire Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply
11/25/2024 07:30 AM EST GlobeNewswire Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference
11/22/2024 07:30 AM EST GlobeNewswire Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide(TM) Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases
11/21/2024 07:30 AM EST GlobeNewswire Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide(TM) Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases
11/14/2024 04:15 PM EST GlobeNewswire Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
11/06/2024 07:30 AM EST GlobeNewswire Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
11/05/2024 07:30 AM EST GlobeNewswire Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024
10/29/2024 07:30 AM EDT GlobeNewswire Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas
Page

Additional News

As of January 3, 2025 • 9:01 PM ET

Date/Time Source News Release
11/16/2024 02:45 PM EST SeekingAlpha Plus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call Transcript
11/14/2024 04:25 PM EST SeekingAlpha Plus Therapeutics GAAP EPS of -$0.37 beats by $0.19, revenue of $1.45M beats by $0.31M
11/14/2024 10:00 AM EST SeekingAlpha Here are the major earnings after the close today
11/13/2024 09:15 AM EST Zacks ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates
11/12/2024 05:40 PM EST Zacks Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates
11/06/2024 08:40 AM EST SeekingAlpha Plus Therapeutics and Spectronrx partner for radiotherapeutic manufacturing
11/04/2024 08:10 AM EST Zacks Zoetis (ZTS) Q3 Earnings and Revenues Beat Estimates
10/04/2024 04:27 PM EDT SeekingAlpha Plus Therapeutics files for $100M mixed securities shelf
09/30/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Mon, Sep 30, 2024 as of 10.00 am ET
09/27/2024 08:45 PM EDT Motley Fool Canada Dividend Stocks That Pay Me More Than $1,380 Per Year
Page